The market size of the Global Smart Nebulizer Market in the year 2021 is valued at 255.49 million and is predicted to reach 738.91 million by the year 2030 at an 12.8% CAGR during the forecast period.
The global healthcare sector is developing to see broad use of nebulizers as a key treatment option for asthma and COPD; the primary demand drivers are an increase in chronic respiratory and associated disorders as well as a rise in demand for and adoption of home healthcare products. In this backdrop, the market for Smart Nebulizers is expected to increase significantly in the following years. Modern technology-enabled nebulizers could be the next major contributor to the growth of the smart nebulizers industry. The availability of alternatives such as Metered-Dose-Inhaler (MDI) and the usage of oral drugs have posed significant barriers to the growth in the adoption of smart nebulizers. To effectively compete with other competitors, prominent companies in the global smart nebulizers market are launching a new product. With the incorporation of cloud computing into nebulizers becoming more prevalent, industry participants expected to invest in the portfolio. Home care nebulizers are expected to gain popularity during the predicted period. Smart Nebulizers Companies are working with a sense of urgency and a consumer focus. Continued innovation supports growth in the worldwide Smart Nebulizers market.
The Smart Nebulizer market is segmented based on the therapeutic areas, component, type of patients and end-users. Based on therapeutic areas, the market is segmented into Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Cystic FibrosisBased on components, the market is segmented as Nebulizer Device, Associated App and Consumables. By types of patients, the market is segmented into Adult Patients and Pediatric Patients. Based on end-users, the market is segmented as hospitals, emergency centres and home healthcare centres.
Based on end-users, the hospitals' segment is accounted as a major contributor in the Smart Nebulizer market.
The hospitals' category is expected to hold a major share in the global Smart Nebulizer market in 2021. because of favorable reimbursement policies and increased patient traffic, Hospitals are an essential component of the healthcare business and the primary source of revenue for the whole industry. As a result, several corporations make significant efforts, both in terms of marketing tactics and income, to promote their products/services in hospitals.
Nebulizer segment witnessed growth at a rapid rate.
The nebulizer segment is projected to proliferate in the global Smart Nebulizer market. The simple and cheap availability of land in developing nations can be related to the shifting manufacture of nebulizer devices. The adoption of newly developed nebulizers with quick medicine delivery combined with a high-end technical assessment with more precision is gaining momentum among the US population, boosting the growth of the global nebulizer devices market, especially in countries such as the US, Germany, the UK, China, and India.
The North America Smart Nebulizer market holds a significant revenue share in the region.
The North America Smart Nebulizer market is expected to register the highest market share in terms of revenue soon. Due to the rising prevalence of asthma and Chronic Obstructive Pulmonary Disease (COPD) in the United States, North America is expected to emerge as a significant growth contributor to the smart nebulizers market. The easy and inexpensive availability of land in emerging nations can be related to the shifting manufacture of nebulizer devices. With significant commercial possibilities in the Asia Pacific, enterprises are concentrating on expanding their product portfolios, diversifying their business operations, lowering costs, increasing customer happiness, and improving the dependability of Smart Nebulizers. The need for Smart Nebulizers is predicted to grow as the number of smokers and pollution levels rise.
The key players in the Smart Nebulizer market have shifted their focus towards bio-based components for product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the Smart Nebulizer market are AireHealth, Becton Dickinson & Company, BioPlus, BPL Medical Technologies, Briggs Healthcare, Briutcare, BriutCare, CA-MI s.r.l., Contec Medical Systems Co.Ltd, DeVilbiss Healthcare L.L.C., FaceLake, Fahl Medizintechnik-Vertrieb GmbH, Guangdong Delong Intelligent Technology CO., Ltd., Hans Dinslage Gmbh, Koninklijke Philips N.V., LAICA International Corporation, Lycome international Industry, MedTech, Microlife AG, Omron Corporation, Ozocheck, PARI Pharma, Pulmotree Medical GMBH, SmartCare, SOMATCO, Sunset Healthcare Solutions Inc., Taidoc Technology Corporation, Vapo Health, Vectura, Wuhan W.E.O. Science & Technology Development, YirDocand and other prominent players.